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Background—Sympathetic nerve activity is important to cardiac arrhythmogenesis.
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Objectives—(1) To develop a method for simultaneous noninvasive recording of skin 
sympathetic nerve activity (SKNA) and electrocardiogram (ECG) using conventional ECG 
electrodes. (2) This method (neuECG) can be used to adequately estimate the sympathetic tone.
Methods—We recorded neuECG signals from the skin in 56 human subjects. The signals were 
low pass filtered to show the ECG and high pass filtered to show nerve activity. Protocol (P)-1 
included 12 healthy volunteers who underwent cold water pressor test (CPT) and Valsalva 
maneuver. P-2 included 19 inpatients with epilepsy but without known heart diseases monitored 
for 24 hours. P-3 included 22 patients admitted with electrical storm and monitored for 39.0±28.2 
hours. P-4 included 3 patients who underwent bilateral stellate ganglion blockade with lidocaine 
injection.
Results—In patients without heart diseases, spontaneous nerve discharges were frequently 
observed at baseline and were associated with heart rate acceleration. The SKNA recorded from 
chest leads (V1–V6) during CPT and Valsalva maneuver (P-1) was invariably higher than during 
baseline and recovery periods (p<0.001). In P-2, the average SKNA correlated with the heart rate 
acceleration (r=0.73±0.14, p<0.05) and shortening of the QT interval (p<0.001). Among 146 
spontaneous ventricular tachycardia episodes recorded in 9 patients of P-3, 106 episodes (73%) 
were preceded by SKNA within 30 s of onset. P4 showed that bilateral stellate ganglia blockade 
by lidocaine inhibited SKNA.
Conclusions—SKNA is detectable using conventional ECG electrodes in humans and may be 
useful in estimating the sympathetic tone.
Keywords
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The standard low pass filter setting of the surface ECG is 150 Hz for adolescents and adults, 
and 250 Hz for children.1 Higher frequency signals are assumed to be noise and eliminated. 
The skin is well innervated by sympathetic nerve fibers.2, 3 The skin nerves in the upper 
extremities and thorax originate in the cervical and stellate ganglia.4, 5 Therefore, it is 
reasonable to hypothesize that skin sympathetic nerve activity (SKNA) of the thorax or 
upper limbs can be used to estimate stellate ganglion nerve activity (SGNA). Consistent with 
the latter hypothesis, our recent canine studies showed that SKNA can be recorded from the 
thorax by filtering the electrogram with high pass filter setting of 150 Hz. Furthermore, we 
showed that the morphology and the magnitude SKNA correlated with SGNA and both 
nerve activities correlated with heart rate (HR) acceleration and preceded the onset of 
ventricular arrhythmias. These findings indicate that SKNA can be used to estimate SGNA 
in ambulatory dogs.6–8 Based on the results of those studies, we hypothesize that it is 
feasible to simultaneously record SKNA and ECG (neuECG) in humans, and that SKNA is 
useful in estimating the sympathetic tone. To test this hypothesis, we recorded neuECG from 
4 different groups of patients. We first tested in a group of normal healthy volunteers if 
maneuvers known to increase sympathetic tone can increase SKNA. A second protocol was 
aimed to perform long term continuous neuECG recording from patients without known 
heart diseases. The data were used to determine if SKNA correlates with HR acceleration 
and QT interval shortening. A third protocol focused on inpatients with ventricular 
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arrhythmias to demonstrate the association between SKNA and the onset of ventricular 
arrhythmias. The fourth protocol was used to further confirm the validity of SKNA in 
estimating SGNA by determining if stellate ganglion blockade can reduce or eliminate the 
SKNA. The data were analyzed to determine if SKNA can be used to non-invasively 
estimate sympathetic tone in humans.
Methods
All protocols were approved by the Institutional Review Boards of the Indiana University, 
Indianapolis, IN, Cedars-Sinai Medical Center, Los Angeles, CA or the Mayo Clinic, 
Rochester, MN. All 56 subjects gave written informed consent to participate. A detailed 
description of study methods, including statistical analyses and the technical details of the 
signal processing techniques used to detect the SKNA, are included in the Online 
Supplement. Recording conditions for each protocol were listed in Supplement Table 1.
Protocol 1: Provocative Maneuvers
We enrolled healthy volunteers for SKNA recording during the cold water pressor test (CPT) 
(N=9) and Valsalva maneuver (VM) (N=8).9 We used this protocol to test various ECG lead 
positions (Supplement Figure 1). The CPT was performed by placing subject’s left hand up 
to the wrist in iced water for 2 minutes.9 The subjects also performed the VM by blowing 
into the mouthpiece of a sphygmomanometer aiming to sustain 35 mmHg of pressure for 30 
s.10 A two-minute control and recovery period were recorded for both maneuvers.
Protocol 2: Continuous Monitoring
Continuous, 24-hr neuECG recordings were done in 19 patients (12 female, age 36±11 
years) with epilepsy but without known heart diseases. The electrode location is shown in 
Supplement Figure 1.
Protocol 3: Electrical Storm
We recorded neuECG from 22 patients (7 female, age 60.6±14) admitted to the hospital with 
electrical storm (ES), defined as three or more separate implantable cardioverter-defibrillator 
(ICD) therapies for ventricular tachycardia (VT) or ventricular fibrillation (VF) over a 24 
hour period.11 We also enrolled patients if they had three or more separate episodes of 
sustained VT or VF over a 24 hour period either prior to ICD insertion or if these fell below 
the ICD detection limit and required external therapy. Electrode placement was identical to 
protocol 2.
Protocol-4: Ganglionic Blockade
We studied a 61 man and a 53 year old man with ischemic cardiomyopathy and a 71 year old 
man with arrhythmogenic right ventricular cardiomyopathy. They underwent bilateral 
stellate ganglion injection with 2% lidocaine (10 ml) while neuECG was being recorded.
Data Analysis
For quantitative analyses, we integrated all digitized SKNA signals over a time window and 
divided the total voltage by the number of digitized samples in the same window to obtain 
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the average voltage of SKNA (aSKNA) per sample. For example, if we used a 10-s window 
and the sampling rate was 10,000 samples/s, then there were a total of 100,000 samples in 
that 10-s window. Assuming the total voltage of all samples in the same window was 
200,000 μV, then the aSKNA was 2 μV. We also rectified and integrated the neurogram every 
100-ms and displayed the results over time to simulate the display methods of 
microneurography.12 The integrated SKNA (iSKNA) was used only to display nerve activity 
in the figures. They were not used in statistical analyses. Only aSKNA was used in statistical 
analyses shown in Table 1. The methods of statistical analyses were included in the Online 
Supplement. Two-sided p values ≤0.05 were considered statistically significant.
Results
Protocol 1
During the CPT, the average mean arterial pressure increased from 87±7 to 105±8 and 
returned to 85±13 mmHg in recovery (p<0.001). Average HR increased from 66±5 to 78±17 
and returned to 61±7 beats per minute (bpm) in recovery (p=0.023). During the VM, the 
average mean arterial pressure increased from 93±7 to 101±12 and returned to 88±8 mmHg 
in recovery (p=0.001). Average HR increased from 67±6 to 85±25 and returned to 65±5 bpm 
in recovery (p=0.025). In the two subjects in whom the impedance was recorded, the average 
impedance for each individual electrode was 37±8 kΩ (range: 28–52 kΩ). Table 1 shows that 
the average SKNA measured in leads tested in ≥ 4 subjects (leads V1–V6 and 2 bipolar 
leads) significantly increased during the CPT and VM, and then reduced significantly during 
recovery.
Figure 1 shows the tracing of a subject at baseline (Panels A and B) and during the VM 
(Panels C and D). Figure 1A shows that spontaneous bursts of nerve activity were associated 
with elevated heart rate. Figure 1B shows basal state nerve discharges. Figure 1C and 1D 
show effects of VM on SKNA.
Figure 2 shows CPT tracings from subjects 1–4 (Panels A–D). SKNA increased prior to 
CPT (arrows), likely due to the anticipation of the impending cold water immersion. 
Massive elevation of SKNA was observed immediately after immersion and remains 
elevated throughout the test, but the HR responses did not always correlate with SKNA. A 
weak correlation between HR and sympathetic nerve activity has also been observed in 
microneurography studies.9, 13 As fingertips do not have skeletal muscles, to address the 
possibility that muscle contraction contributed to signal increase when electrodes were 
placed on or across the chest wall, for subjects 5–7 we placed the two electrodes in a bipolar 
montage with electrodes on the 2nd and 3rd digits, respectively, of the non-immersed hand 
(Supplement Figure 1, Protocol 1-Configuration 2). The reference was on the ipsilateral 
thumb. While there was an increase in average SKNA during CPT, the magnitude was 
smaller than in most other electrode positions (Table 1). Placing the electrodes further apart 
on the non-immersed arm of subjects 11 and 12 (Supplement Figure 1, Protocol 1-
Configuration 3) generated visible and statistically significant increase (Table 1).
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Protocol 2
Out of 190 SKNA discharges, 189 were followed by HR acceleration (Figure 3A and 3B). 
The average HR increased by 12.36±0.48 bpm [95% CI 11.43–13.30 bpm] from 71.38±0.67 
bpm to 83.74±0.77 bpm (p<0.05). The average Pearson’s correlation coefficient between 
average SKNA in leads I and II was 0.83±0.13, between lead I average SKNA and the HR 
was 0.73±0.14 and between lead II average SKNA and the HR was 0.67±0.13 (p<0.05 for 
all). Data for each individual patient is included in Supplement Table 2. Compared to the 10 
s before the beginning of the SKNA discharge, a significant increase in average SKNA was 
noted in both leads (by 1.15±0.86 [95% CI 1.02–1.27 μV] in lead I and by 0.96±0.88 [95% 
CI 0.84–1.09 μV] in lead II, p<0.05 for both) in the 10 s window after the onset of SKNA 
discharge. We randomly selected additional 190 episodes of SKNA. The SKNA was 
associated with QT interval shortening from 387±24 ms to 369±24 ms (p<0.001) but with 
increased QTc from 420±25 ms to 458±27 ms (p<0.001) (Figure 3C). These findings were 
consistent with the QT interval responses of normal subjects to sympathetic stimulation.14
Protocol 3
The characteristics of all electrical storm patients are listed in Supplemental Table 3. The 
recordings lasted for 39.0±28.2 hours. Ten of the 22 patients had recurrent VT on the 
recording, one of which was predominantly in incessant hemodynamically stable VT and 
had over 400 non-sustained monomorphic VT episodes with HR around 120 bpm. The first 
400 non-sustained VT episodes in the patient with incessant VT while on the recording were 
selected and all of them were preceded by SKNA discharges in both leads I and II. This 
patient also had 2 episodes of VT lasting ≥30 s and many nerve discharges were observed 
during VT (Figure 4A). The other 9 patients accounted for 146 separate VT episodes with a 
HR of 208±68 bpm and duration of 34±253 s (range 1–2983 s). The majority of those 
episodes were non-sustained (34% non-sustained monomorphic VT, 58% non-sustained 
polymorphic VT) with sustained (> 30 s or requiring therapy) VT representing only 8%. A 
total of 73% of VT episodes were preceded by discharges in lead I (Figure 4B, subject B) 
and 38% were preceded by discharges in lead II. By using generalized linear mixed model, 
the odds ratio of having discharge 30 s before the VT versus during the 30 s control periods 
(109 episodes, 12±13, range:1–33 per patient) 20 min after the VT episodes for a specific 
patient as detected by lead I was 7.45 [95% CI 3.14–17.72], p<0.0001). No significant 
difference was noted for lead II. While there was an association between SKNA in Lead I 
and VT, these findings alone did not prove that SKNA caused VT episodes.
Similar to prior canine studies,7 pacemaker spikes could not be completely filtered despite 
500 Hz high pass filtering (Figure 4C). In half of the patients the signal to noise ratio was 
poor with the nerve discharges reaching a signal to noise ratio ≥ 2:1 only for several ms 
(Figure 5A). External defibrillation (Figure 5B) and anti-tachycardia pacing (Figure 5C and 
5D) increased SKNA. High pass filtering at 150 Hz (middle panel) improves the signal to 
noise ratio (Figure 5C and 5D).
Protocol-4
The injection protocol included inserting needles under fluoroscopic guidance and local 
contrast injection to ascertain the location of the needle. During these procedures, the patient 
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had significant SKNA activation. Lidocaine injection into the stellate ganglia reduced SKNA 
in all 3 patients studied (Figure 6).
Discussion
In this manuscript we report a new method to record sympathetic nerve activity from the 
surface of the skin. Chest wall SKNA showed temporal patterns of response to CPT and VM 
that closely resemble those of microneurographic recordings of subcutaneous sympathetic 
nerve activity: a) anticipatory bursts immediately preceding performance of these 
provocative maneuvers; b) rapid onset and rapid peak of the increase in SKNA which 
progressively lessens during continued performance of the maneuver; c) lack of pulse-
synchronous sympathetic bursts and lack of reciprocal changes to fluctuations in blood 
pressure, indicating lack of arterial baroreflex regulation. The latter is also evident during 
spontaneous premature ventricular contractions (the falling diastolic blood pressure during 
the compensatory pause did not trigger a large burst of SKNA). We found that spontaneous 
bursts of chest wall SKNA were followed by an abrupt increase of heart rate at basal state in 
patients without heart diseases and preceded 73% of spontaneous VT episodes in 9 VT 
patients. Lidocaine injection into the stellate ganglia suppressed SKNA. Taken together, 
these data strongly suggest that SKNA may be useful in estimating sympathetic tone. 
Because skin is easily accessible, this new method of SKNA recording may be useful to a 
broad spectrum of physiological and pathophysiological investigations.
SGNA and SKNA
Stellate ganglion was a major source of cardiac innervation. While it was difficult to record 
stellate ganglion nerve activity (SGNA) in humans, we had successfully recorded SGNA 
from ambulatory animals.15 The SGNA was broad based and not pulse synchronous,16 thus 
was morphologically more similar to subcutaneous sympathetic nerve activity than muscle 
sympathetic nerve activity as recorded by microneurography.17–19 Subsequently we were 
able to use bipolar electrodes to simultaneously record SGNA, SKNA and subcutaneous 
nerve activity (SCNA) in ambulatory dogs.6, 8 The results showed that the morphology and 
magnitude of SCNA and SKNA indeed resembled that of the SGNA. Both SGNA and 
SCNA preceded the heart rate acceleration in basal state and the onset of spontaneous 
ventricular arrhythmias in a canine model of sudden death.7 However, we do not have actual 
SGNA recordings from humans to confirm the correlation between SKNA and SGNA in this 
study.
Effects of ganglionic blockade and activation
When microneurography techniques were initially invented, the investigators confirmed the 
sympathetic origin of these high frequency signals by performing either local or ganglionic 
blockade procedures.20 In the present study, we also showed that ganglionic blockade 
inhibited the SKNA, indicating that SKNA contains post-ganglionic sympathetic nerve 
activity. We previously showed in a canine model that local injection of apamin into the 
stellate ganglion can directly result in simultaneous activation of SGNA and SKNA, 
indicating that the stellate ganglion is a source of both electrical activities.8 More recent 
study from our laboratory showed that in ambulatory rats, peritoneal injection of neurotoxic 
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6-hydroxydopamine resulted in a progressive and significant reduction of SCNA, again 
indicating the sympathetic origin of these signals.21 Putting these data together, we propose 
that SKNA recording provides a useful non-invasive estimation of sympathetic tone.
Filter settings
Like all diagnostic tests, specificity can be increased only at the cost of reduction in 
sensitivity and vice versa. A high pass filter setting of 150 Hz eliminates ECG but not all 
muscle noise. While most muscle activity had a frequency of <100 Hz,22 small amount of 
muscle activities could reach 400 Hz.23 A 500 Hz high pass filter setting is thus more 
specific for recording neurogram, but a large majority of the nerve signals are filtered out 
(thus lowers the sensitivity). In comparison, the high pass filter settings of the 
microneurography studies typically ranged between 400 Hz to 700 Hz.12, 24 In addition to 
low frequency noise, the patient care areas may have electrical equipment that emits high 
frequency noise. When high frequency noise is present, high pass filtering the signals alone 
may be insufficient. Bandpass filtering might be needed to optimize the signal to noise ratio. 
Figure 2 in the Online Supplement illustrates the relationship between filter setting and the 
signal to noise ratio.
Limitations of the study
Microneurography studies can selectively record from muscle and skin sympathetic nerves. 
On the other hand, SKNA recordings use skin patch electrodes, which might simultaneously 
detect both skin and muscle sympathetic nerve activities. Further studies will be needed to 
determine how much of these two different types of signals are represented in the SKNA 
recordings.
Conclusions
We conclude that SKNA is detectable using conventional ECG electrodes in humans and 
may be useful in estimating the sympathetic tone.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
neuECG recordings from subject 12 of Protocol 1. Signals from Lead V1 were bandpass 
filtered between 500 Hz and 1000 Hz to detect SKNA and bandpass filtered between 0.5 Hz 
and 150 Hz to detect ECG. Integrated SKNA (iSKNA) was calculated over 100 ms window. 
A: Increased SKNA was associated with heart rate (HR) acceleration. B: Higher 
magnification of SKNA showing baseline spontaneous nerve activities (a) and large 
variations of nerve discharges associated with tachycardia (b). C: increased SKNA and HR 
were evident during Valsalva maneuver (VM); dotted red lines mark the start and the stop of 
the maneuver. D shows the magnified boxed segment from C, showing phases II–IV of the 
VM and demonstrating that the SKNA is not synchronous with the QRS complex.
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Figure 2. 
neuECG recordings during the cold water pressor test (CPT) in Protocol 1. The electrode 
location was on the right and left arm for ECG Lead I recording. A–D: Increased skin 
sympathetic nerve activity (SKNA) was detected in subjects 1–4, respectively, during the 
CPT. Black downward arrows point to increased SKNA prior to CPT, likely due to the 
anticipation of the impending cold water immersion. The increased SKNA was associated 
with heart rate acceleration in patients 1–3, but not in patient 4. Integrated SKNA (iSKNA) 
shows the total SKNA over 100 ms windows after applying 500 Hz high pass filter. HR= 
heart rate, bmp=beats per minute.
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Figure 3. 
neuECG recording in patients without known heart diseases in Protocol 2. The neuECG 
electrodes were placed on the chest to form Lead I and Lead II. A shows baseline recording 
in leads I and II filtered at either 150 Hz or 500 Hz high pass to display SKNA and low pass 
filtered at 10 Hz to display the ECG. B shows an episode of SKNA associated with heart rate 
(HR) acceleration (downward arrows). The 150 Hz high pass filter resulted in better signal 
to noise ratio and higher amplitude of SKNA, but some ECG signals remained (upward 
arrows). High pass filter at 500 Hz largely eliminated the ECG signals, but also reduced 
nerve amplitude and the signal to noise ratio. The baseline artifact on the surface ECG 
occurred after the onset of SKNA, suggesting motion artifacts induced by muscle movement. 
C shows SKNA (500 Hz high pass, Lead II) and ECG tracings (125 Hz low pass) from a 
different patient. There was abrupt increase of HR from 101 beats per minute (bpm) to a 
maximum (max) of 132 bpm after SKNA activation, along with QT interval shortening. D 
shows the enlarged ECG from line segments a and b in C. Both the RR and the QT interval 
shortened after SKNA. E shows a 90 s recording at baseline, illustrating spontaneous SKNA 
episodes and their relationship with HR. HP=high pass, LP=low pass, bpm=beats per 
minute.
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Figure 4. 
SKNA during sustained VT and before nonsustained VT. The neuECG electrodes were 
placed on the chest to form Lead I and Lead II. A: Nerve discharges (arrows) are noted 
throughout monomorphic ventricular tachycardia (VT). Signals simultaneously obtained 
from ECG lead I with the top panel representing the signal after 500 Hz high pass (HP) filter 
and the bottom panel displaying the raw signal. B: Similar discharges are observed in 
another patient preceding non-sustained VT. Signal simultaneously obtained from ECG lead 
II, the top panel is filtered at 500 Hz high pass and the bottom ECG is filtered at 10 Hz low 
pass. C: Pacing artifacts (downward arrows) are observed despite 500 Hz high pass filtering. 
Increased high frequency SKNA is still evident (upward arrow) beginning 90 s prior to VT. 
The bottom panel shows the boxed segment from the middle panel and the onset of VT. 
VT=ventricular tachycardia, ECG=electrocardiogram, HP=500 Hz high pass filter, LP=10 
Hz low pass filter, SKNA=skin sympathetic nerve activity.
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Figure 5. 
Further examples of SKNA and VT. A: Increased nerve activity, including a large spike 
(arrow) is noted in lead I in a intubated and sedated patient with electrical storm after 500 
Hz high pass filtering. The signal is better appreciated in the middle panel after rectification 
and baseline adjustment. The simultaneous raw electrocardiogram (ECG) is displayed in the 
bottom panel and shows both premature ventircular contractions and a brief run of 
polymorphic VT. B displays similar simultaneous recordings in the same patient during 
sustained VT requiring external defibrillation (arrow, top panel). The defibrillation was 
followed immediately by large SKNA. The shock was only transiently successful, followed 
by recurrences of VT. Recordings from C and D are from another patient with VT and are 
continuous. In this recording after high pass filtering, the signal to noise ratio of SKNA prior 
to VT in C, top and middle panel does not reach 2:1. High pass filtering at 150 Hz again 
improves the signal to noise ratio (downward arrows, C). However as the arrhythmia 
continues in D and the patient’s device delivers successful burst of anti-tachycardia pacing 
(downward arrows, bottom panel), incraesed SKNA is detected both with 500 Hz high pass 
filter and 150 Hz high pass filter. VT=ventricular tachycardia, ECG=electrocardiogram, 
SKNA=skin sympathetic nerve activity.
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Figure 6. 
Effects of lidocaine (10 ml, 2 %) stellate ganglion block on SKNA continuously recorded 
from the right arm. A shows patient 1. Needle insertion (black arrows) was followed by 
activation of SKNA. Lidocaine injection (red arrows) into the LSG transiently reduced 
SKNA. However, RSG injection was followed by a significant reduction of SKNA. Panels B 
and C show responses to lidocaine injection in the remaining 2 patients. The gaps in 
tachogram (small black upward arrows) occurred because artifacts prevented automated 
selections of the R waves.
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